CXCR4 and neoplasm: Due to theheterogeneous nature of the MDA-MB-231 cell population, the studysubsequently investigated the effects of lower doses and combinationtreatments to optimize therapeutic outcomes. The inhibition of CXCR4 prevents breast cancercells from metastasizing to distant organs such as bones and lungs.,